4//SEC Filing
Ruth Matthew R. 4
Accession 0001385508-21-000096
CIK 0001385508other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:09 PM ET
Size
7.7 KB
Accession
0001385508-21-000096
Insider Transaction Report
Form 4
Ruth Matthew R.
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-07-19+50,000→ 50,000 totalExercise: $16.41From: 2022-07-12Exp: 2031-07-11→ Common Stock (50,000 underlying) - Award
Common Stock
2021-07-19+15,000→ 15,000 total
Footnotes (2)
- [F1]15,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of July 12, 2022, July 12, 2023, July 12, 2024 and July 12, 2025, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]On July 19, 2021, the reporting person was granted 50,000 incentive stock options. Each option represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the options vest on the anniversary dates of July 12, 2022, July 12, 2023, July 12, 2024 and July 12, 2025, subject to the Reporting Person continuing as a service provider through such date.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001872022
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:09 PM ET
- Size
- 7.7 KB